Summary: There is no clinically superior day to start GLP-1 receptor agonist therapy, but beginning at a weekend or during reduced commitments allows time to monitor initial side effects
The Healthline pharmacist guidance specifically lists added sugar as a trigger for digestive side effects
In the context of the Melanotan II pathway, this is relevant because Melanotan II is a melanocortin receptor agonist, and MC1R is one of the receptor-family members that responds to melanocortin-related signaling
doi: 10.3389/fnut.2022.853058 Received 12 January 2022 Accepted 11 February 2022 Published 14 March 2022 Volume 9 - 2022 Edited by Anna Maria Giudetti, University of Salento, Italy Reviewed by Stefan Kabisch, Charit Universittsmedizin Berlin, Germany
Trimethylamine oxide (TMAO) is a metabolite produced by the intestinal microbiome from carnitine and choline, two compounds present in large quantities in red meat such as beef and pork